Soluble interleukin-2 receptor release defect in vitro in elderly subjects
- 14 June 1991
- journal article
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 59 (1-2) , 27-35
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- HLA-DR3 and immunoresponsivenessThe Lancet, 1990
- Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1990
- HLA‐B8,DR3 PHENOTYPE AND LYMPHOCYTE RESPONSES TO PHYTOHAEMAGGLUTININInternational Journal of Immunogenetics, 1990
- Soluble Interleukin-2 Receptor Secretion Defect in Vitro in HLA-B8, DR3 Positive SubjectsAutoimmunity, 1990
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989
- Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseasesClinical Immunology and Immunopathology, 1989
- The role of T cell phenotypes in decreased lymphoproliferation of the elderlyClinical Immunology and Immunopathology, 1989
- Heterogeneity of immune responsiveness in healthy elderly subjectsClinical Immunology and Immunopathology, 1988
- Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors.Journal of Clinical Investigation, 1988
- B-Cell Stimulatory Factor-1/Interleukin 4Annual Review of Immunology, 1987